In doing so, it blocks lipopolysaccharide (LPS)-induced inflammatory mediators such as tumor necrosis factor (TNF)-α and IL-6 in vitro (both in murine macrophages and human peripheral blood monocytes-hPBMC) and reduces endotoxemia, in vivo [11]. The gene discussed is TNF; the disease is serum lipopolysaccharide activity.